# US 8,280,488 B2 · Processing and displaying dynamic contrast-enhanced magnetic resonance imaging information

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,280,488 B2
- Document ID: US8280488B2
- Status: Granted
- Kind: B2
- Application number: 11/604,083
- Filed: 2006-11-24
- Published: 2008-05-29
- Granted: 2012-10-02
- Earliest claimed: 2006-11-24
- Inventors: Henkjan J. Huisman; Nico Karssemeijer
- Web page: https://patentgrep.com/patent/US8280488B2

## CPC

- A61B 5/055: involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- A61B 5/14546: {for measuring analytes not otherwise provided for, e.g. ions, cytochromes}
- A61B 5/708: {Breast positioning means}
- G01R 33/5601: {involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent}
- G01R 33/56366: {Perfusion imaging}
- A61B 5/7267: {involving training the classification device}
- G01R 33/281: {Means for the use of in vitro contrast agents (G01R33/282 takes precedence; involving use of a contrast agent in MR imaging G01R33/5601; in vivo contrast agents A61K49/0002)}
- G01R 33/5608: {Data processing and visualization specially adapted for MR, e.g. for feature analysis and pattern recognition on the basis of measured MR data, segmentation of measured MR data, edge contour detection on the basis of measured MR data, for enhancing measured MR data in terms of signal-to-noise ratio by means of noise filtering or apodization, for enhancing measured MR data in terms of resolution by means for deblurring, windowing, zero filling, or generation of gray-scaled images, colour-coded images or images displaying vectors instead of pixels (image data processing or generation, in general G06T)}
- G01R 33/56308: {Characterization of motion or flow; Dynamic imaging}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)

## Abstract

A method, system, and related computer program products for processing and displaying dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) information are described. A plurality of instances of an MRI volume of the body part acquired at a respective plurality of sample times subsequent to an administration of a tracer is processed to determine a plurality of pharmacokinetic (PK) parameters characterizing a mathematical model-based relationship between a plasma tracer concentration and a total tracer concentration within the body part. For one preferred embodiment, computation of the PK parameters is performed according to a generalized signal model such that computation can be carried out in real time during an interactive viewer session, with required reference regions being selectable and optionally re-selectable by the viewer without requiring extensive waiting times for PK parameter computation. Associated user interfaces and computer-aided detection (CAD) algorithms are also provided.

## Claims

### Claim 1

A method for dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of a body part of a patient to determine a plurality of pharmacokinetic (PK) parameters characterizing a mathematical model-based relationship between a plasma tracer concentration and a total tracer concentration within the body part, comprising:
receiving a plurality of instances of an MRI volume of the body part acquired at a respective plurality of sample times subsequent to an administration of a tracer, said instances comprising voxels of MRI readings timewise variable according to the total tracer concentration but scalewise uncalibrated therewith in that the voxels of MRI readings are not determinative of calibrated absolute values for said total tracer concentration;
for each of said voxels, using a processing system, processing said scalewise uncalibrated MRI readings to compute a first parameter set characteristic of said timewise variations thereof according to a predetermined generalized signal model of a tracer concentration time response, said predetermined generalized signal model being separable between (i) a first subset of generalized signal model parameters determinative of timewise variations of the tracer concentration time response, and (ii) a second subset of generalized signal model parameters determinative of a scale of the tracer concentration time response, said first parameter set corresponding to said first subset of generalized signal model parameters for said MRI readings;
receiving an identification of a calibration region within said MRI volume;
for each of said voxels, processing said scalewise uncalibrated MRI readings against information derived from said identified calibration region to compute a second parameter set characteristic of a scale of said total tracer concentration, said second parameter set corresponding to said second subset of generalized signal model parameters for said total tracer concentration;
receiving an identification of at least one plasma reference region within said MRI volume having known reference PK parameters;
computing a third parameter set characteristic of timewise variations of a representative plasma tracer concentration according to said predetermined generalized signal model and fourth parameter set characteristic of a scale of the representative plasma tracer concentration according to said predetermined generalized signal model based on the first and second parameter sets for locations in the at least one identified plasma reference region and said reference PK parameters therefor; and
computing said plurality of PK parameters for each of said voxels using said first, second, third and fourth parameter sets.

### Claim 2 (depends on 1)

The method of claim 1, said identification of at least one plasma reference region being an identification of at least one first plasma reference region, the method further comprising:
receiving an identification of at least one second plasma reference region different than said at least one first plasma reference region and having known reference PK parameters;
recomputing said third and fourth parameter sets based on the first and second parameter sets for locations in the at least one second plasma reference region and said reference PK parameters therefor; and
recomputing said plurality of PK parameters for each of said voxels using said first parameter set, said second parameter set, and said recomputed third and fourth parameter sets;
whereby said plurality of PK parameters are recomputed based on an identification of at least one different plasma reference region without requiring recomputation of said first and second parameter sets.

### Claim 3 (depends on 1)

The method of claim 1, wherein said body part comprises of one of a breast and a prostate, and wherein said at least one plasma reference region comprises one of pectoral muscle tissue and left ventricular volume.

### Claim 4 (depends on 3)

The method of claim 3, wherein said at least one plasma reference region comprises at least three separate plasma reference regions.

### Claim 5 (depends on 1)

The method of claim 1, said identified calibration region being a first calibration region, the method further comprising:
receiving an identification of a second calibration region within said MRI volume;
for each of said voxels, recomputing said second parameter set by processing said scalewise uncalibrated MRI readings against information derived from said identified second calibration region;
recomputing said fourth parameter set based on said recomputed second parameter sets for locations in the at least one identified plasma reference region and said reference PK parameters therefor; and
recomputing said plurality of PK parameters for each of said voxels using said first parameter set, said recomputed second parameter set, said third parameter set, and said recomputed fourth parameter set;
whereby said plurality of PK parameters are recomputed based on an identification of at least one different calibration region without requiring recomputation of said first and third parameter sets.

### Claim 6 (depends on 2)

The method of claim 2, wherein said calibration region and said plasma reference region are automatically segmented by computer processing of the MRI volume.

### Claim 7 (depends on 2)

The method of claim 2, wherein said calibration region and said plasma reference region are manually identified by a viewer.

### Claim 8 (depends on 1)

The method of claim 1, wherein said plurality of pharmacokinetic parameters comprises an extra-cellular tissue volume ratio (ve), a bolus arrival time (t0), and a tracer transfer constant (Ktrans).

### Claim 9 (depends on 1)

The method of claim 1, further comprising displaying a map of at least one of said plurality of pharmacokinetic parameters as an overlay to a viewable MRI volume corresponding to said MRI volume.

### Claim 10

A method for dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of a body part of a patient to determine a plurality of pharmacokinetic (PK) parameters characterizing a mathematical model-based relationship between a plasma tracer concentration and a total tracer concentration within the body part, comprising:
receiving a plurality of instances of an MRI volume of the body part acquired at a respective plurality of sample times subsequent to an administration of a tracer, said instances comprising voxels of MRI readings variable according to the total tracer concentration but scalewise uncalibrated therewith in that the voxels of MRI readings are not determinative of calibrated absolute values for said total tracer concentration;
prior to an interactive display session, using a processing system, processing said scalewise uncalibrated MRI readings to compute a first parameter set characteristic of said timewise variations thereof according to a predetermined generalized signal model of a tracer concentration time response, said predetermined generalized signal model being separable between (i) a first subset of generalized signal model parameters determinative of timewise variations of the tracer concentration time response, and (ii) a second subset of generalized signal model parameters determinative of a scale of the tracer concentration time response, said first parameter set corresponding to said first subset of generalized signal model parameters for said MRI readings;
during the interactive display session, receiving a user identification of a calibration region within said MRI volume; and
computing said PK parameters for all voxels in said MRI volume using said first parameter set, said uncalibrated MRI readings, and information derived from said identified calibration region within a real time interval after receiving said user identification, comprising:
computing a second parameter set corresponding to said second subset of generalized signal model parameters for said total tracer concentration, said first and second parameter sets forming a total tracer concentration parameter set;
computing a third parameter set characteristic of timewise variations of a representative plasma tracer concentration according to said predetermined generalized signal model and fourth parameter set characteristic of a scale of the representative plasma tracer concentration according to said predetermined generalized signal model based on the first and second parameter sets for locations in at least one identified plasma reference region and a plurality of reference PK parameters associated therewith; and
computing said plurality of PK parameters for each of said voxels using said first, and second, third and fourth parameter sets.

### Claim 11 (depends on 10)

The method of claim 10, wherein said third and fourth parameter sets forming a plasma tracer concentration parameter set, said generating the third and fourth parameter sets comprising modifying said total concentration parameter set for voxels within said at least one plasma reference region using substantially arithmetic computations, and said computing said plurality of PK parameters for each of said voxels comprising using substantially arithmetic operations on said total concentration parameter set and said plasma concentration parameter set.

### Claim 12 (depends on 11)

The method of claim 11, wherein said at least one plasma reference region comprises one of pectoral muscle tissue and left ventricular volume.

### Claim 13 (depends on 11)

The method of claim 11, wherein said at least one plasma reference region comprises at least three separate plasma reference regions.

### Claim 14 (depends on 10)

The method of claim 10, wherein said body part comprises of one of a breast and a prostate.

### Claim 15 (depends on 10)

The method of claim 10, wherein said plurality of pharmacokinetic parameters comprises an extra-cellular tissue volume ratio (ve), a bolus arrival time (t0), and a tracer transfer constant (Ktrans).

### Claim 16 (depends on 10)

The method of claim 10, further comprising displaying a map of at least one of said plurality of pharmacokinetic parameters as an overlay to a viewable MRI volume corresponding to said MRI volume.

### Claim 17

A method for interactive processing and display of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) information, comprising:
(i) prior to an interactive user session:
receiving a plurality of instances of an MRI volume of a body part acquired at a respective plurality of sample times subsequent to an administration of a tracer, said instances comprising voxels of MRI readings that are timewise variable according to a total tracer concentration but scalewise uncalibrated therewith in that the voxels of MRI readings are not determinative of calibrated absolute values for said total tracer concentration; and
for each of said voxels, using a processing system, processing said scalewise uncalibrated MRI readings to compute a first parameter set characteristic of said timewise variations thereof according to a predetermined generalized signal model of a tracer concentration time response, said predetermined generalized signal model being separable between (i) a first subset of generalized signal model parameters determinative of timewise variations of the tracer concentration time response, and (ii) a second subset of generalized signal model parameters determinative of a scale of the tracer concentration time response, said first parameter set corresponding to said first subset of generalized signal model parameters for said MRI readings;
(ii) receiving an identification of the voxels of the MRI volume corresponding to at least one reference region;
(iii) during the interactive user session:
receiving a first user input determinative of information from which scalewise calibration of the MRI readings with the total tracer concentration can be performed for each voxel;
for each of said voxels, performing said scalewise calibration for at least two of said MRI readings using said first user input;
for each of said voxels, computing a second parameter set using said at least two scalewise calibrated MRI readings, said second parameter set corresponding to said second subset of generalized signal model parameters for said total tracer concentration; and
for each of said voxels lying outside the at least one reference region, computing each of said plurality of PK parameters using (a) said first and second parameter sets for that voxel, and (b) representative first and second parameter sets for said identified voxels in said at least one reference region, said representative first parameter set being characteristic of timewise variations of a representative plasma tracer concentration according to said predetermined generalized signal model and said representative second parameter set being characteristic of a scale of the representative plasma tracer concentration according to said predetermined generalized signal model, said representative first and second parameter sets being based on said first and second parameter sets for locations in at least one identified plasma reference region and a plurality of reference PK parameters associated therewith;
wherein said performing said scalewise calibration, said computing the second parameter set, and said computing each of said plurality of PK parameters are of minor computational intensity compared to said computing the first parameter set and are performed in a real-time interval across all of said voxels during said interactive user session.

### Claim 18 (depends on 17)

The method of claim 17, wherein said body part comprises of one of a breast and a prostate.

### Claim 19 (depends on 17)

The method of claim 17, wherein said plurality of pharmacokinetic parameters comprises an extra-cellular tissue volume ratio (ve), a bolus arrival time (t0), and a tracer transfer constant (Ktrans).

### Claim 20 (depends on 17)

The method of claim 17, further comprising displaying a map of at least one of said plurality of pharmacokinetic parameters as an overlay to a viewable MRI volume corresponding to said MRI volume.
